carbamazepine has been researched along with warfarin in 62 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 10 (16.13) | 18.7374 |
1990's | 4 (6.45) | 18.2507 |
2000's | 19 (30.65) | 29.6817 |
2010's | 28 (45.16) | 24.3611 |
2020's | 1 (1.61) | 2.80 |
Authors | Studies |
---|---|
Andrews, PR; Craik, DJ; Martin, JL | 1 |
Topliss, JG; Yoshida, F | 1 |
Faller, B; Wohnsland, F | 1 |
Alvarez-Pedraglio, A; Colmenarejo, G; Lavandera, JL | 1 |
Hwang, KK; Mandagere, AK; Thompson, TN | 1 |
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
Artursson, P; Bergström, CA; Hoogstraate, J; Matsson, P; Norinder, U; Pedersen, JM | 1 |
Ahlin, G; Artursson, P; Bergström, CA; Gustavsson, L; Karlsson, J; Larsson, R; Matsson, P; Norinder, U; Pedersen, JM | 1 |
Botta, M; Dreassi, E; Falchi, F; Maga, G; Santucci, A; Schenone, S; Zizzari, AT | 1 |
Chen, L; He, Z; Li, H; Liu, J; Liu, X; Sui, X; Sun, J; Wang, Y; Zhang, W | 1 |
Erdmann, F; Fischer, G; Harris, R; Hopkins, S; Huang, Z; Murray, MG; Ribeill, Y; Scorneaux, B; Smitley, C; Wring, S | 1 |
Conradi, R; Lee, PH; Shanmugasundaram, V | 1 |
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM | 1 |
Avdeef, A; Tam, KY | 1 |
Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ | 1 |
Ekins, S; Williams, AJ; Xu, JJ | 1 |
Boriss, H; Braggio, S; Corbioli, S; Fontana, S; Helmdach, L; Longhi, R; Schiller, J; Vinco, F | 1 |
Claxton, CR; Curran, RE; Harradine, PJ; Hutchison, L; Littlewood, P; Martin, IJ | 1 |
Annand, R; Gozalbes, R; Jacewicz, M; Pineda-Lucena, A; Tsaioun, K | 1 |
Honda, K; Izumi, T; Miyaji, Y; Nakayama, S; Okazaki, O; Okudaira, N; Shiosakai, K; Sugiyama, D; Suzuki, W; Takakusa, H; Watanabe, A | 1 |
Chang, G; Di, L; Huang, Y; Lin, Z; Liston, TE; Scott, DO; Troutman, MD; Umland, JP | 1 |
Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V | 1 |
Barber, S; Dew, TP; Farrell, TL; Poquet, L; Williamson, G | 1 |
Artursson, P; Haglund, U; Karlgren, M; Kimoto, E; Lai, Y; Norinder, U; Vildhede, A; Wisniewski, JR | 1 |
Ambroso, JL; Ayrton, AD; Baines, IA; Bloomer, JC; Chen, L; Clarke, SE; Ellens, HM; Harrell, AW; Lovatt, CA; Reese, MJ; Sakatis, MZ; Taylor, MA; Yang, EY | 1 |
Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ | 1 |
Blair, A; Boyd, M; Chalmers, AJ; Malviya, G; Pimlott, SL; Sutherland, A; Zmuda, F | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Jones, LH; Nadanaciva, S; Rana, P; Will, Y | 1 |
Azas, N; Boudot, C; Bourgeade-Delmas, S; Boutet-Robinet, E; Courtioux, B; Fairlamb, A; Hutter, S; Laget, M; Moreau, A; Mothes, E; Paloque, L; Pedron, J; Pratviel, G; Sournia-Saquet, A; Stigliani, JL; Valentin, A; Vendier, L; Verhaeghe, P; Wyllie, S | 1 |
Denbow, CE; Fraser, HS | 1 |
Raasch, RH | 1 |
Baciewicz, AM | 1 |
Altman, H; Howrie, DL; Maroon, TJ; Zitelli, BJ | 1 |
Jacobs, HD | 1 |
Müller, FO; Steyn, JM | 1 |
D'Arcy, PF | 1 |
Massey, EW | 1 |
Beeley, L; Ross, JR | 1 |
Boivin, M; Kendall, AG | 1 |
Felstead, S | 1 |
Hirayama, F; Iizumi, Y; Kawasaki, T; Koshio, H; Matsumoto, Y; Sato, K; Taniuchi, Y | 1 |
Havlat, M; Kontogiannis, V; Lowe, JS; Powell, RJ | 1 |
Akdemir, O; Aktoz, M; Cakir, N; Celik, Y; Pamuk, ON; Soy, M | 1 |
Adams, RC; Furness, MS; Gill, DS; Holcombe, FO; Raw, AS; Yu, LX | 1 |
Hage, DS; Kim, HS | 1 |
Breskvar, K; Dolzan, V; Grabnar, I; Herman, D; Lainscak, M; Locatelli, I; Mrhar, A; Peternel, P; Stegnar, M | 1 |
O'donnell, PJ; Parrish, RH; Pazdur, DE | 1 |
Barron, L; Paull, B; Tobin, J | 1 |
Peuravuori, J; Pihlaja, K | 1 |
Hage, DS; Yoo, MJ | 1 |
Baysan, O; Nevruz, O; Yokuşoğlu, M | 1 |
Marison, IW; von Stockar, U; Whelehan, M | 1 |
Mushiroda, T | 1 |
Aomori, T; Fujita, Y; Kiyotani, K; Nakamura, K; Nakamura, T; Obayashi, K; Sato, H; Yamamoto, K | 1 |
Aminkeng, F; Bhavsar, AP; Carleton, BC; Hayden, MR; Lee, JW; Ross, CJ; Shaw, K | 1 |
Bi, C; Hage, DS; Podariu, M; Zheng, X | 1 |
Andersson, ML; Järnbert-Pettersson, H; Lindh, JD; Mannheimer, B | 1 |
Clark, NP; Delate, T; Hoang, K; Horn, JR; Witt, DM | 1 |
de Abajo, FJ; Gaist, D; Martín-Pérez, M; Rodríguez, LAG | 1 |
Alsaidi, AT; Bauer, J; Cruz, A; Macfarlane, C; Morris, SA; Patel, JN; Verbyla, A | 1 |
7 review(s) available for carbamazepine and warfarin
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Carbamazepine drug interactions.
Topics: Carbamazepine; Cimetidine; Dextropropoxyphene; Drug Interactions; Erythromycin; Humans; Isoniazid; Lithium; Phenobarbital; Phenytoin; Primidone; Protein Binding; Troleandomycin; Valproic Acid; Warfarin | 1986 |
Mitral valve vegetation and cerebral emboli in a primary antiphospholipid syndrome patient who had hepatitis C virus infection: report of a case and review of the literature.
Topics: Adult; Antibodies, Anticardiolipin; Anticoagulants; Anticonvulsants; Antiphospholipid Syndrome; Carbamazepine; Echocardiography, Doppler; Endocarditis; Epilepsy; Female; Hepatitis C; Humans; Intracranial Embolism; Magnetic Resonance Imaging; Mitral Valve Insufficiency; Warfarin | 2003 |
Regulatory considerations of pharmaceutical solid polymorphism in Abbreviated New Drug Applications (ANDAs).
Topics: Biological Availability; Carbamazepine; Cefuroxime; Chemistry Techniques, Analytical; Crystallography; Decision Trees; Drug Approval; Drug Stability; Drugs, Generic; Enalapril; Humans; Molecular Conformation; Phase Transition; Prazosin; Quality Control; Ranitidine; Solubility; Sulfonamides; Technology, Pharmaceutical; Therapeutic Equivalency; Torsemide; United States; United States Food and Drug Administration; Warfarin | 2004 |
[Challenge in genome-wide association study for establishment of personalized medicine: focusing on the pharmacogenomics of warfarin and carbamazepine].
Topics: Carbamazepine; Genome-Wide Association Study; Genotype; Humans; Pharmacogenetics; Precision Medicine; Warfarin | 2013 |
The emerging era of pharmacogenomics: current successes, future potential, and challenges.
Topics: Anthracyclines; Biomarkers, Pharmacological; Carbamazepine; Cisplatin; Codeine; Genetic Testing; Genetic Variation; Humans; Pharmacogenetics; Precision Medicine; Warfarin | 2014 |
Cost Effectiveness of Pharmacogenetic Testing for Drugs with Clinical Pharmacogenetics Implementation Consortium (CPIC) Guidelines: A Systematic Review.
Topics: Carbamazepine; Cost-Benefit Analysis; Humans; Pharmacogenetics; Pharmacogenomic Testing; Warfarin | 2022 |
3 trial(s) available for carbamazepine and warfarin
Article | Year |
---|---|
Clinical evaluation of side-effects of drugs.
Topics: Accident Prevention; Aged; Anti-Bacterial Agents; Anticoagulants; Carbamazepine; Dibenzazepines; Drug Hypersensitivity; Drug Interactions; Drug-Related Side Effects and Adverse Reactions; Evaluation Studies as Topic; Female; Humans; Length of Stay; Male; Middle Aged; Migraine Disorders; Pharmaceutical Preparations; Phenobarbital; Placebos; Warfarin | 1973 |
The influence of co-treatment with carbamazepine, amiodarone and statins on warfarin metabolism and maintenance dose.
Topics: Aged; Aged, 80 and over; Amiodarone; Aryl Hydrocarbon Hydroxylases; Carbamazepine; Cytochrome P-450 CYP2C9; Dose-Response Relationship, Drug; Drug Interactions; Drug Therapy, Combination; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Middle Aged; Pharmacokinetics; Warfarin | 2006 |
Warfarin Interaction With Hepatic Cytochrome P-450 Enzyme-Inducing Anticonvulsants.
Topics: Aged; Aged, 80 and over; Anticonvulsants; Carbamazepine; Cytochrome P-450 Enzyme Inducers; Drug Interactions; Follow-Up Studies; Humans; International Normalized Ratio; Middle Aged; Warfarin | 2018 |
52 other study(ies) available for carbamazepine and warfarin
Article | Year |
---|---|
Functional group contributions to drug-receptor interactions.
Topics: Animals; Calorimetry; Kinetics; Models, Biological; Protein Binding; Receptors, Cell Surface; Receptors, Drug; Structure-Activity Relationship | 1984 |
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
High-throughput permeability pH profile and high-throughput alkane/water log P with artificial membranes.
Topics: Alkanes; Humans; Hydrogen-Ion Concentration; Intestinal Absorption; Membranes, Artificial; Octanols; Permeability; Pharmaceutical Preparations; Solubility; Water | 2001 |
Cheminformatic models to predict binding affinities to human serum albumin.
Topics: Adrenergic beta-Antagonists; Antidepressive Agents, Tricyclic; Chromatography, Affinity; Cyclooxygenase Inhibitors; Databases, Factual; Humans; Hydrophobic and Hydrophilic Interactions; Penicillins; Pharmaceutical Preparations; Protein Binding; Quantitative Structure-Activity Relationship; Reproducibility of Results; Serum Albumin; Steroids | 2001 |
Graphical model for estimating oral bioavailability of drugs in humans and other species from their Caco-2 permeability and in vitro liver enzyme metabolic stability rates.
Topics: Administration, Oral; Animals; Biological Availability; Caco-2 Cells; Dogs; Guinea Pigs; Humans; In Vitro Techniques; Inactivation, Metabolic; Liver; Microsomes, Liver; Models, Biological; Permeability; Pharmacokinetics; Rats; Species Specificity | 2002 |
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Prediction and identification of drug interactions with the human ATP-binding cassette transporter multidrug-resistance associated protein 2 (MRP2; ABCC2).
Topics: Administration, Oral; Animals; Antineoplastic Agents; Antipsychotic Agents; Antiviral Agents; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Biological Transport; Cell Line; Computer Simulation; Cytochrome P-450 Enzyme System; Drug-Related Side Effects and Adverse Reactions; Estradiol; Humans; Insecta; Liver; Models, Molecular; Multidrug Resistance-Associated Protein 2; Multidrug Resistance-Associated Proteins; Neoplasm Proteins; Pharmaceutical Preparations; Pharmacology; Structure-Activity Relationship | 2008 |
Structural requirements for drug inhibition of the liver specific human organic cation transport protein 1.
Topics: Cell Line; Computer Simulation; Drug Design; Gene Expression Profiling; Humans; Hydrogen Bonding; Liver; Molecular Weight; Organic Cation Transporter 1; Pharmaceutical Preparations; Predictive Value of Tests; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Structure-Activity Relationship | 2008 |
Determination of permeability and lipophilicity of pyrazolo-pyrimidine tyrosine kinase inhibitors and correlation with biological data.
Topics: Humans; Lipids; Membranes, Artificial; Permeability; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-abl; Pyrazoles; Pyrimidines | 2009 |
Prediction of volume of distribution values in human using immobilized artificial membrane partitioning coefficients, the fraction of compound ionized and plasma protein binding data.
Topics: Blood Proteins; Chemistry, Physical; Computer Simulation; Humans; Membranes, Artificial; Models, Biological; Pharmaceutical Preparations; Protein Binding; Tissue Distribution | 2009 |
SCY-635, a novel nonimmunosuppressive analog of cyclosporine that exhibits potent inhibition of hepatitis C virus RNA replication in vitro.
Topics: Animals; Antiviral Agents; Cell Line; Cells, Cultured; Cyclophilin A; Cyclosporins; Dogs; Dose-Response Relationship, Drug; Enzyme Activation; Haplorhini; Hepacivirus; Hepatitis C; Hepatocytes; Humans; Immunosuppressive Agents; Interleukin-2; Jurkat Cells; Leukocytes, Mononuclear; Mice; Molecular Structure; Rats; RNA, Viral; Virus Replication | 2010 |
Development of an in silico model for human skin permeation based on a Franz cell skin permeability assay.
Topics: 1-Methyl-3-isobutylxanthine; Cell Line; Cell Membrane Permeability; Humans; Models, Biological; Quantitative Structure-Activity Relationship; Skin Absorption | 2010 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
Topics: | 2008 |
How well can the Caco-2/Madin-Darby canine kidney models predict effective human jejunal permeability?
Topics: Animals; Disease Models, Animal; Dogs; Humans; Jejunal Diseases; Kidney Diseases; Models, Biological; Permeability; Porosity; Regression Analysis | 2010 |
Developing structure-activity relationships for the prediction of hepatotoxicity.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
Brain tissue binding of drugs: evaluation and validation of solid supported porcine brain membrane vesicles (TRANSIL) as a novel high-throughput method.
Topics: Absorption; Albumins; Animals; Brain; Brain Chemistry; Cell Membrane; Chromatography, High Pressure Liquid; Drug Evaluation, Preclinical; In Vitro Techniques; Lipids; Male; Microdialysis; Pharmaceutical Preparations; Protein Binding; Rats; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Swine; Tissue Distribution | 2011 |
Control and measurement of plasma pH in equilibrium dialysis: influence on drug plasma protein binding.
Topics: Animals; Blood Proteins; Buffers; Carbon Dioxide; Chemical Phenomena; Dialysis; Dogs; Drug Evaluation, Preclinical; Humans; Hydrogen-Ion Concentration; Macaca fascicularis; Mice; Osmolar Concentration; Pharmaceutical Preparations; Protein Binding; Rats; Reproducibility of Results | 2011 |
QSAR-based permeability model for drug-like compounds.
Topics: Caco-2 Cells; Cell Membrane Permeability; Drug Discovery; Humans; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship | 2011 |
Combination of GSH trapping and time-dependent inhibition assays as a predictive method of drugs generating highly reactive metabolites.
Topics: Glutathione; Pharmacology; Sulfur Radioisotopes | 2011 |
Species independence in brain tissue binding using brain homogenates.
Topics: Animals; Brain; Dogs; Guinea Pigs; Humans; Macaca fascicularis; Mice; Rats; Species Specificity | 2011 |
FDA-approved drug labeling for the study of drug-induced liver injury.
Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration | 2011 |
Predicting phenolic acid absorption in Caco-2 cells: a theoretical permeability model and mechanistic study.
Topics: Artificial Intelligence; Caco-2 Cells; Cell Membrane Permeability; Cinnamates; Enterocytes; Humans; Hydrophobic and Hydrophilic Interactions; Intestinal Absorption; Kinetics; Models, Biological; Molecular Conformation; Osmolar Concentration; Phenols | 2012 |
Classification of inhibitors of hepatic organic anion transporting polypeptides (OATPs): influence of protein expression on drug-drug interactions.
Topics: Atorvastatin; Biological Transport; Drug Interactions; Estradiol; Estrone; HEK293 Cells; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; In Vitro Techniques; Least-Squares Analysis; Liver; Liver-Specific Organic Anion Transporter 1; Models, Molecular; Multivariate Analysis; Organic Anion Transporters; Organic Anion Transporters, Sodium-Independent; Protein Isoforms; Pyrroles; Solute Carrier Organic Anion Transporter Family Member 1B3; Structure-Activity Relationship; Transfection | 2012 |
Preclinical strategy to reduce clinical hepatotoxicity using in vitro bioactivation data for >200 compounds.
Topics: Chemical and Drug Induced Liver Injury; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Decision Trees; Drug Evaluation, Preclinical; Drug-Related Side Effects and Adverse Reactions; Glutathione; Humans; Liver; Pharmaceutical Preparations; Protein Binding | 2012 |
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship | 2012 |
Synthesis and Evaluation of a Radioiodinated Tracer with Specificity for Poly(ADP-ribose) Polymerase-1 (PARP-1) in Vivo.
Topics: Animals; Cell Line, Tumor; Enzyme Inhibitors; Glioblastoma; Humans; Iodine Radioisotopes; Mice; Mice, Nude; Phthalazines; Piperazines; Poly (ADP-Ribose) Polymerase-1; Poly(ADP-ribose) Polymerase Inhibitors; Poly(ADP-ribose) Polymerases; Tissue Distribution; Tomography, Emission-Computed, Single-Photon | 2015 |
Development of a cell viability assay to assess drug metabolite structure-toxicity relationships.
Topics: Adenosine Triphosphate; Benzbromarone; Cell Line; Cell Survival; Chromans; Cytochrome P-450 CYP2C9; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Humans; Pharmaceutical Preparations; Thiazolidinediones; Troglitazone | 2016 |
Novel 8-nitroquinolin-2(1H)-ones as NTR-bioactivated antikinetoplastid molecules: Synthesis, electrochemical and SAR study.
Topics: Antiprotozoal Agents; Cell Survival; Dose-Response Relationship, Drug; Electrochemical Techniques; Hep G2 Cells; Humans; Kinetoplastida; Leishmania infantum; Molecular Structure; Nitroquinolines; Nitroreductases; Parasitic Sensitivity Tests; Structure-Activity Relationship; Trypanosoma brucei brucei | 2018 |
Clinically significant hemorrhage due to warfarin-carbamazepine interaction.
Topics: Carbamazepine; Drug Interactions; Ecchymosis; Female; Humans; Middle Aged; Prothrombin Time; Substance Withdrawal Syndrome; Warfarin | 1990 |
Interactions of oral antibiotics and common chronic medications.
Topics: Administration, Oral; Adrenergic beta-Antagonists; Aged; Allopurinol; Ampicillin; Antacids; Anti-Bacterial Agents; Anticonvulsants; Carbamazepine; Digoxin; Drug Combinations; Drug Interactions; Erythromycin; Humans; Sulfamethoxazole; Sulfonamides; Sulfonylurea Compounds; Tetracycline; Theophylline; Trimethoprim; Trimethoprim, Sulfamethoxazole Drug Combination; Warfarin | 1987 |
Erythromycin-induced drug interactions. An illustrative case and review of the literature.
Topics: Carbamazepine; Child; Cyclosporins; Digoxin; Drug Interactions; Erythromycin; Female; Humans; Metabolic Clearance Rate; Theophylline; Warfarin | 1987 |
Comparative effects of two commercially available blood collection tubes on plasma concentrations of drugs.
Topics: Acebutolol; Blood Specimen Collection; Carbamazepine; Diazepam; Digoxin; Ethosuximide; Humans; Nordazepam; Penbutolol; Pharmaceutical Preparations; Propranolol; Quinidine; Salicylates; Time Factors; Valproic Acid; Warfarin | 1980 |
Early reports on drug interactions.
Topics: Acetaminophen; Amiodarone; Apazone; Aspirin; Carbamazepine; Chlordiazepoxide; Cimetidine; Coumarins; Drug Interactions; Erythromycin; Ethanol; Furosemide; Gentamicins; Humans; Levodopa; Lidocaine; Phenytoin; Prenylamine; Quinidine | 1983 |
Effect of carbamazepine on Coumadin metabolism.
Topics: Carbamazepine; Drug Interactions; Humans; Warfarin | 1983 |
Interaction between carbamazepine and warfarin.
Topics: Carbamazepine; Drug Interactions; Humans; Male; Middle Aged; Prothrombin Time; Warfarin | 1980 |
Warfarin-carbamazepine interaction.
Topics: Carbamazepine; Drug Interactions; Humans; Prothrombin Time; Warfarin | 1981 |
Azithromycin drug interactions.
Topics: Anti-Bacterial Agents; Azithromycin; Carbamazepine; Digoxin; Drug Interactions; Ergotamine; In Vitro Techniques; Methylprednisolone; Prothrombin Time; Terfenadine; Theophylline; Warfarin | 1995 |
Comparison of the anticoagulant and antithrombotic effects of YM-75466, a novel orally-active factor Xa inhibitor, and warfarin in mice.
Topics: Administration, Oral; Analgesics, Non-Narcotic; Animals; Anti-Bacterial Agents; Anticoagulants; Anticonvulsants; Antifibrinolytic Agents; Blood Coagulation; Carbamazepine; Cimetidine; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Interactions; Erythromycin; Factor Xa Inhibitors; Fibrinolytic Agents; Hemorrhage; Male; Mice; Mice, Inbred ICR; Partial Thromboplastin Time; Phenytoin; Piperidines; Prothrombin Time; Rifampin; Sulfonamides; Thromboembolism; Thromboplastin; Vitamin K 1; Warfarin | 1998 |
Lesson of the month: Systemic vasculitis or not? That is the question.
Topics: Acetates; Amines; Anticoagulants; Anticonvulsants; Brain; Carbamazepine; Central Nervous System Diseases; Clotrimazole; Cyclohexanecarboxylic Acids; Cyclophosphamide; Drug Hypersensitivity; Drug Therapy, Combination; Gabapentin; gamma-Aminobutyric Acid; Humans; Immunosuppressive Agents; Liver; Magnetic Resonance Imaging; Male; Middle Aged; Vasculitis; Vasculitis, Leukocytoclastic, Cutaneous; Warfarin | 1999 |
Chromatographic analysis of carbamazepine binding to human serum albumin.
Topics: Allosteric Site; Binding Sites; Binding, Competitive; Carbamazepine; Chromatography, Affinity; Humans; Models, Chemical; Protein Binding; Serum Albumin; Thermodynamics; Tryptophan; Warfarin | 2005 |
Effect of carbamazepine initiation and discontinuation on antithrombotic control in a patient receiving warfarin: case report and review of the literature.
Topics: Aged; Analgesics, Non-Narcotic; Anticoagulants; Atrial Fibrillation; Carbamazepine; Drug Interactions; Facial Pain; Female; Humans; International Normalized Ratio; Stroke; Thrombosis; Warfarin | 2006 |
Multi-residue determination of pharmaceuticals in sludge and sludge enriched soils using pressurized liquid extraction, solid phase extraction and liquid chromatography with tandem mass spectrometry.
Topics: Analgesics, Non-Narcotic; Anticoagulants; Carbamazepine; Chromatography, Liquid; Environmental Monitoring; Fertilizers; Pharmaceutical Preparations; Sewage; Soil Pollutants; Solid Phase Extraction; Tandem Mass Spectrometry; Time Factors; Warfarin; Water Pollutants, Chemical | 2008 |
Phototransformations of selected pharmaceuticals under low-energy UVA-vis and powerful UVB-UVA irradiations in aqueous solutions--the role of natural dissolved organic chromophoric material.
Topics: Carbamazepine; Ibuprofen; Kinetics; Metoprolol; Molecular Structure; Molecular Weight; Nitrates; Photochemical Processes; Solid Phase Extraction; Solubility; Solutions; Ultraviolet Rays; Warfarin | 2009 |
Evaluation of silica monoliths in affinity microcolumns for high-throughput analysis of drug-protein interactions.
Topics: Anticoagulants; Anticonvulsants; Carbamazepine; Chromatography, High Pressure Liquid; Humans; Molecular Structure; Serum Albumin; Silicon Dioxide; Warfarin | 2009 |
Warfarin resistance induced by oxcarbamazepine.
Topics: Blood Coagulation; Carbamazepine; Drug Interactions; Drug Resistance; Humans; Warfarin | 2009 |
Removal of pharmaceuticals from water: using liquid-core microcapsules as a novel approach.
Topics: Capsules; Carbamazepine; Clofibric Acid; Diclofenac; Environmental Monitoring; Feasibility Studies; Fresh Water; Furosemide; Kinetics; Metoprolol; Pharmaceutical Preparations; Reproducibility of Results; Sulfamethoxazole; Warfarin; Water Pollutants, Chemical; Water Purification; Water Supply | 2010 |
Case report: dose adjustment of warfarin using genetic information and plasma concentration monitoring.
Topics: Aged; Anticoagulants; Carbamazepine; Cytochrome P-450 CYP2C9 Inducers; Drug Antagonism; Female; Genotype; Humans; International Normalized Ratio; Pharmacogenetics; Vitamin K Epoxide Reductases; Warfarin | 2014 |
Development of enhanced capacity affinity microcolumns by using a hybrid of protein cross-linking/modification and immobilization.
Topics: Carbamazepine; Chemistry Techniques, Analytical; Chromatography, Affinity; Humans; Maleimides; Proteins; Serum Albumin; Sulfhydryl Compounds; Warfarin | 2015 |
The effect of carbamazepine on warfarin anticoagulation: a register-based nationwide cohort study involving the Swedish population.
Topics: Age Factors; Aged; Aged, 80 and over; Anticoagulants; Brain Ischemia; Carbamazepine; Drug Administration Schedule; Drug Interactions; Drug Therapy, Combination; Female; Humans; International Normalized Ratio; Male; Middle Aged; Registries; Retrospective Studies; Sex Factors; Stroke; Sweden; Warfarin | 2016 |
Population Impact of Drug Interactions with Warfarin: A Real-World Data Approach.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amiodarone; Anticoagulants; Carbamazepine; Databases, Factual; Drug Interactions; Female; Fluconazole; Follow-Up Studies; Humans; International Normalized Ratio; Male; Miconazole; Middle Aged; Nystatin; Primary Health Care; Retrospective Studies; United Kingdom; Warfarin; Young Adult | 2018 |